Total tumour mutational burden (TMB) correlated significantly with BCR repertoire diversity and IgG frequency in individual tumour regions from patients with LUAD, but not with TLS or B cell signatures (Extended Data Fig. 9a), in line with prior reports6. The gene discussed is BCR; the disease is neoplasm.